Quadrivalent human papillomavirus vaccine and autoimmune adverse events: a case–control assessment of the vaccine adverse event reporting system (VAERS) database [PDF]
, 2016 core +1 more source
Safety assessment of rosuvastatin-fenofibrate combination in the treatment of hyperlipidemia based on FDA’s adverse event reporting system database [PDF]
Qun Li, Wenya Shan, Shasha Wu
openalex +1 more source
Disproportionality analysis of vibegron-associated adverse events using the FDA adverse event reporting system (FAERS): a real-world pharmacovigilance study [PDF]
B. Y. C. Wan +3 more
openalex +1 more source
Drug-induced liver injury associated with lopinavir-ritonavir in patients with COVID-19: a disproportionality analysis of U.S. food and drug administration adverse event reporting system (FAERS) data [PDF]
, 2021 Huilin Tang +7 more
openalex +1 more source
Liver injury with novel oral anticoagulants: assessing post‐marketing reports in the US Food and Drug Administration adverse event reporting system [PDF]
, 2015 Emanuel Raschi +8 more
openalex +1 more source
RWD65 Novel Adverse Events of CGRP Receptor Antagonists: A Disproportionality Analysis in USFDA Adverse Event Reporting System Database [PDF]
, 2023 Ankita Ashok Sangnure +3 more
openalex +1 more source
Hepatic dysfunction events associated with voriconazole: a real-world study from FDA adverse event reporting system (FAERS) database [PDF]
, 2023 Juping Yun +4 more
openalex +1 more source
Olfactory‐Related Adverse Events: An Analysis of the Food and Drug Administration Adverse Events Reporting System [PDF]
, 2023 Katrina Minutello +6 more
openalex +1 more source
Fixed drug eruption and generalized bullous fixed drug eruption: Insights from an analysis of the FDA Adverse Event Reporting System [PDF]
Pragya Shrestha +2 more
openalex +1 more source
A disproportionality analysis of FDA adverse event reporting system (FAERS) events for filgotinib. [PDF]
PLoS OneShi Y +7 more
europepmc +1 more source